• Open: 8-5 M-T and 8-12 F
Retaxome Daily Retinal Hydrator

Retaxome Daily Retinal Hydrator

$145.00

Retinal, encapsulated in a biomimetic exosome, delivers greater potency, faster results, and more precise delivery while also lessening the risk of irritation.
Category

Retaxome Daily Retinal Hydrator

Retinal, encapsulated in a biomimetic exosome, delivers greater potency, faster results, and more precise delivery while also lessening the risk of irritation.

Regenerative Medicine Meets Retinal Therapy

A Groundbreaking Molecule

In this proprietary process, retinal is fused with biomimetic exosome delivery technology, stabilizing the retinal inside the exosomes core — shielding it from degradation and delivering deep into the skin.

Retinal

RetaXome delivers stabilized retinaldehyde deep into the dermal layer to activate cell turnover and stimulate collagen and elastin synthesis.

Centella Asiatica

To boost the power of RetaXome, the biomimetic exosome is loaded with Centella Asiatica, a medicinal plant known to accelerate healing bio-compounds and reduce inflammation.

Precision Retinal Starts with RetaXome

RetaXome™ Daily Retinal Hydrator is a proprietary, next-generation retinal-infused exosome that sets the new gold standard in regenerative retinoid therapy, offering high-dose, targeted delivery deep into the dermis — where it matters most.

TRIPLE ACTION INNOVATION…

BIOMIMETIC EXOSOME

This innovative retinal-infused exosome enables precise cell-to-cell communication.

RETINAL

Highly potent one-conversion retinoid formulated for tolerability & accelerated results.

SUPERCHARGED HA

Formulated with dual-weight, 100% injectable-grade hyaluronic acid.

DELIVERS KEY BENEFITS…

DEEPER DELIVERY

Up to 20x deeper penetration of retinal compared to “free-form” retinal.

HIGH TOLERABILITY

A nightly-use formula designed for immediate comfort and continuous visible results.

HYDRATING RETINOID

The only retinal clinically validated to deeply hydrate and balance the skin.

Renewal. Radiance. Results.

STUDY OVERVIEW

A 12-week single-center, IRB-approved, open-label study was conducted with 20 female patients (ages 35-65, Fitz I-VI), presenting with mild to moderate fine lines, wrinkles, and photodamage. Investigators performed objective assessments at baseline and at weeks 2, 4, 8, and 12.

Visible Improvement in Fine Lines & Wrinkles

*Unretouched clinical study participant. Individual results may vary

Visible Improvement in Skin Tone

*Unretouched clinical study participant. Individual results may vary

STUDY OVERVIEW

Patients used Prelude Facial Treatment Cleanser, applied RetaXome Daily Retinal Hydrator in the evening, followed with Cetaphil Moisturizing Lotion, and used sunscreen as needed.

STUDY OVERVIEW

A 12-week single-center, IRB-approved, open-label study was conducted with 20 female patients (ages 35-65, Fitz I-VI), presenting with mild to moderate fine lines, wrinkles, and photodamage. Investigators performed objective assessments at baseline and at weeks 2, 4, 8, and 12.

Powered By EmbedPress

Related products